T. Rowe Price Associates’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-23,200
| Closed | -$27K | – | 2940 |
|
|
2022
Q3 | $27K | Hold |
23,200
| – | – | ﹤0.01% | 2894 |
|
|
2022
Q2 | $34K | Hold |
23,200
| – | – | ﹤0.01% | 2893 |
|
|
2022
Q1 | $53K | Buy |
23,200
+11,300
| +95% | +$25.8K | ﹤0.01% | 2909 |
|
|
2021
Q4 | $33K | Buy |
+11,900
| New | +$33K | ﹤0.01% | 2944 |
|
|
2021
Q3 | – | Sell |
-37,200
| Closed | -$181K | – | 2940 |
|
|
2021
Q2 | $181K | Sell |
37,200
-12,400
| -25% | -$60.3K | ﹤0.01% | 2744 |
|
|
2021
Q1 | $123K | Buy |
+49,600
| New | +$123K | ﹤0.01% | 2761 |
|